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A statistical study on dystrophins recorded amino acid mutations that lead to 
Dystrophin’s non-function associated with muscular dystrophy. I hypothesize that 
certain key residues have a higher frequency for a mutation occurring than others 
in dystrophin. I also hypothesize that through this statistical analysis the 
reasoning of why certain mutations cause Duchenne muscular dystrophy (DMD: 
severe) vs Becker muscular dystrophy (BMD: not so severe) can be determined.  
The analysis was completed through correlating the frequency of certain types of 
mutations and relating them to the location, the diagnosis, and the overall 
functionality of the protein. Secondly, I hypothesize that through thermodynamic 
processes on certain mutant construction of dystrophin, correlation of structure 
and function can be tested directly.*   
 
*Data from the thermodynamic constructs are still being gathered and analysis. 
Predicted date of thermodynamic construct data publication: Dec 2015.  
 
 
1. Introduction 
 
Muscular dystrophy is a class of inherited diseases that causes the muscle tissue to weaken or 
lose the ability to function. The two diseases, Duchenne and Becker muscular dystrophy 
originate from the same gene but have drastically different severities. Duchenne patients usually 
die wheelchair bound in their early 20s while Becker patients live long lives with minor 
symptoms. Understanding genetically why these two diseases vary will be beneficial for 
researchers to develop a treatment or cure to the crippling Duchenne’s disease. Dystrophin is a 
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long protein that acts as a shock absorber between muscle cells. Dystrophin links actin and 
dystroglycans of the sarcolemma and is key to preventing damage in the cells (Ishpekova, 1999). 
In Duchenne patients the dystrophin fails to function or fails to be produced. The lack of 
dystrophin or its function is catastrophic to the muscle tissue. Damage is easy created to muscle 
for the cells lack the natural “shock absorber”. In recent studies Le Rumeur and his team (2010) 
found dystrophin also assists in regulating calcium levels in muscle cells. The regulation of 
calcium in muscle cells is key to their function (Le Rumeur, 2010). Without particular calcium 
concentrations muscle cells fail to repair themselves. The constant damage to cells also causes 
scar tissue to develop in the connective tissue (Bhattacharya, 2014). The lack of repair and 
buildup of scar tissue causes the loss of function in muscle tissue. Duchenne muscular dystrophin 
is only seen in young boys. This is because the dystrophin gene (DMD) is an X-linked protein. 
 
2. Methods 
 
Using Leiden Muscular Dystrophy Mutation Database all the mutations (substitution, deletion, 
insertion, frame shift, and duplication) pertaining to DMD and BMD were mapped out in the 
structure of dystrophin; the control being the normal strand sequence for dystrophin. Each 
mutation’s original source was validated to assure the mutations from the database were 
authentic. Leiden Muscular Dystrophy Mutation Database pools documented mutations from 
around the world. Validations of mutations are as follows: originated from human being, a 
patient diagnosed with muscular dystrophy, from a licensed and creditable institution. Once 
mutations were validated, they were then mapped on the structure of dystrophin pertaining to the 
protein’s domains. Frequency (number of recorded incidents for that specific mutation) on each 
amino acid was then documented and statically analyzed using random and probability factors. 
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3. Results 
 
Figure 1 and Table 1. Displayed are the validated recorded mutations for both DMD and BMD 
on the structure of dystrophin. The width of the colored lines is a pixel. Every pixel represents an 
amino acid. The graphic composed is a precise size display of each domain of dystrophin in 
regards to the number of amino acids it contains. The domains are labeled accordingly. The 
colored lines for the mutations correspond to the type of mutation; red (frame-shift), yellow 
(substitutions), blue (insertion or deletion). The table is the number of mutation recorded 
respectfully to each region.  
 
Figure 2 and Table 2. Above displays only the substitution mutations for DMD and BMD on 
dystrophin. The size of the graphic is still a precise representation of domain size. There is an 
amino acid ruler placed above and below the graphics to be used as guides to finding desired 
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amino acid. The amino acid numbers listed in the tables correlate to the amino acid counting 
from the N-terminus. The ‘Recorded #’ is the number of patients that have been recorded to 
possess that specific mutation.  
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4. Discussion 
 
The dystrophin mutations causing DMD/BMD were very wide spread throughout the protein. 
The amount of mutations recorded in each structural region was divided by the total amount of 
amino acids in that domain to determine the percentage mutated in Figure 1. This was done to 
determine if there was anyone domain region that was key to the proteins function. Based on the 
results it appears that every region plays a role in the proteins proper function. The highest 
region of mutation occurrence is 33.19% in the Actin Binding domain (ABD1). Further analysis 
of ABD1 is being complete currently with dystrophin constructs being analyzed 
thermodynamically. Looking at only the single substitution mutations determined if there is any 
one key residue that is important to function as well as the given region in the protein. Looking 
at data no clear region determined DMD specific or BMD specific. Currently there is not a large 
enough sample size to do a statistical comparison if a mutation is solely DMD or BMD. DMD 
reoccurrence for amino acid 1745 was significantly higher than the rest, however this mutation 
also reoccurred in BMD patient. Further investigation is need on the exact amino acid 
substitution and property changes to determine if there are significant differences between the 
mutations at the amino acid residue for DMD and BMD patients. As well as doing informatics in 
the currently, lab differential scanning calorimetry is being completed on the ABD1 region of 
dystrophin. This shows the stability differences of ABD1 vs the protein as a whole. How ABD1 
responds to changing temperature as well as how stable it is within its environment. The results 
display a simple mapping of all the current mutations based on domain region and mutation type. 
From this data no clear correlation between domain region and disease is shown. 
 
5. Conclusion 
 
Currently this research is being continued. Further analysis of the amino acids substitution and 
regions is being completed as well as the purification of dystrophin mutation constructs to 
determine thermodynamic significance. This research will be continued throughout this year to 
determine the key differences between DMD and BMD mutation as well as dystrophin’s 
response to lab rendered mutations. 
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